-
1m 25sPart 1 | Session 1 Welcome and Introduction
-
14m 12sPart 1 | Session 2 Evolut in SAPIEN
-
16m 29sPart 1 | Session 3 Evolut in Evolut
-
17m 38sPart 1 | Session 4 SAPIEN in Evolut & Explant Data
-
4m 19sPart 1 | Session 5 Live Q&A Panel
-
1m 23sPart 2 | Session 1 Welcome and Introduction
-
14m 19sPart 2 | Session 2 Evolut in SAPIEN
-
11m 49sPart 2 | Session 3 Evolut in Evolut
-
16m 10sPart 2 | Session 4 TAVR Explant
The Future of TAVR: Redo TAV webinar series showcases the latest approaches to managing redo TAV procedures. Join the first in the series where Guilherme Attizzani (Cleveland, US), Cezar S. Staniloae (New York, US) Chad Rammohan (Mountain View & Redwood City, US) and Toby Rogers (Washington, US) feature step-by-step CT case planning and valve sizing, followed by an engaging case-based discussion of redo TAV scenarios, including how different TAVR valve combinations influenced planning and outcomes. Practical insights were shared on how experts approached these cases in real-world practice.
• Expert implanters shared cases addressing common procedural and clinical best practices and tips
• Terminology, redo TAV combination considerations and planning principles were reviewed
• Precision planning focused on the role of CT in redo TAV and procedural strategies
• Future TAVR principles were incorporated when considering index TAV and redo TAV
Key Learning Objectives
- Understand CT sizing, case planning and CT algorithm for Redo TAV with Evolut
- Address common procedural and clinical challenges using practical insights and solutions identified from real-world physician experience
- Apply case-based clinical decision-making to select appropriate treatment approaches across a range of redo TAV scenarios
- Evaluate TAVR and redo TAV treatment pathways within the context of patient's lifespan
Target Audience
- Interventional Cardiologists
- Structural Heart Intervention Specialist
- Cardiac Imaging Specialists
- Cardiothoracic surgeon
More from this programme
Part 1
The Future of TAVR: Redo TAV - Session I
Part 2
The Future of TAVR: Redo TAV - Session 2
Faculty Biographies
Anita W Asgar
Interventional Cardiologist
Dr Anita Asgar is an Interventional Cardiologist working at the Montreal Heart Institute, and Associate Professor of Medicine at the University of Montreal.
Dr Asgar specialises in transcatheter valve interventions, congenital interventions and cardiac MRI. She is the lead cardiologist for the transcatheter mitral/tricuspid valve program at the Montreal Heart Institute. Her research interests include the treatment and management of valvular heart disease and cost-effectiveness analysis and she is currently the Director of Transcatheter Valve Therapy Research at the Montreal Heart Institute.
Jaffar Khan
Interventional Cardiologist
Dr Jaffar Khan is an Interventional Cardiologist at St. Francis Hospital & Heart Center in Roslyn, NY. He is a leading expert in structural heart disease with a focus on transcatheter aortic and mitral valve interventions. Dr. Khan has been involved in landmark clinical trials and is recognized for his contributions to advancing minimally invasive cardiac procedures.
Clinton D. Kemp
Cardiac Surgeon
Dr Clinton D. Kemp is a Cardiac Surgeon at Sentara in Norfolk, VA. He specializes in complex cardiac surgical procedures including TAVR explant and redo structural heart interventions. Dr. Kemp is a key member of the multidisciplinary heart team and has extensive experience managing patients with failed transcatheter valves requiring surgical or repeat transcatheter solutions.
Matthew W. Sherwood
Interventional Cardiologist
Dr Matthew W. Sherwood is an Interventional Cardiologist at Inova's Structural Heart Disease Program in Fairfax, VA. He has built a high-volume practice in transcatheter structural heart interventions, with a special interest in Redo TAV and complex valve-in-valve cases. Dr. Sherwood is dedicated to advancing the field through clinical research and physician education.